Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.
Kosmider O, Possémé C, Templé M, Corneau A, Carbone F, Duroyon E, Breillat P, Chirayath TW, Oules B, Sohier P, Luka M, Gobeaux C, Lazaro E, Outh R, Le Guenno G, Lifermann F, Berleur M, Le Mene M, Friedrich C, Lenormand C, Weitten T, Guillotin V, Burroni B, Boussier J, Willems L, Aractingi S, Dionet L, Tharaux PL, Vergier B, Raynaud P, Ea HK, Ménager M, Duffy D, Terrier B. Kosmider O, et al. Among authors: aractingi s. Nat Commun. 2024 Jan 30;15(1):910. doi: 10.1038/s41467-024-44811-4. Nat Commun. 2024. PMID: 38291039 Free PMC article.
SARS-CoV-2 vaccination may trigger and exacerbate mucosal lichen planus.
Dangien A, Darbord D, Chanal J, Wendling J, Pantoja C, Oules B, Lheure C, Ouedraogo E, Kramkimel N, Barret M, Beuvon F, Plantier F, Guegan S, Aractingi S, Seta V, Sohier P, Isnard C, Dupin N. Dangien A, et al. Among authors: aractingi s. J Eur Acad Dermatol Venereol. 2023 Sep;37(9):e1094-e1096. doi: 10.1111/jdv.19144. Epub 2023 May 6. J Eur Acad Dermatol Venereol. 2023. PMID: 37114298 No abstract available.
Unusually Aggressive Actinic Keratosis of the Eyelid and Conjunctiva.
Al-Hage J, Masliah-Planchon J, Sohier P, Lumbroso-Rouic L, Bieche I, Aractingi S. Al-Hage J, et al. Among authors: aractingi s. Acta Derm Venereol. 2023 Aug 22;103:adv4500. doi: 10.2340/actadv.v103.4500. Acta Derm Venereol. 2023. PMID: 37605896 Free PMC article. No abstract available.
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients.
Puszkiel A, Bianconi G, Pasquiers B, Balakirouchenane D, Arrondeau J, Boudou-Rouquette P, Bretagne MC, Salem JE, Declèves X, Vidal M, Kramkimel N, Guegan S, Aractingi S, Huillard O, Alexandre J, Wislez M, Goldwasser F, Blanchet B. Puszkiel A, et al. Among authors: aractingi s. Br J Cancer. 2024 Mar 26. doi: 10.1038/s41416-024-02659-x. Online ahead of print. Br J Cancer. 2024. PMID: 38532102
Role of MR1-driven signals and amphiregulin on the recruitment and repair function of MAIT cells during skin wound healing.
du Halgouet A, Darbois A, Alkobtawi M, Mestdagh M, Alphonse A, Premel V, Yvorra T, Colombeau L, Rodriguez R, Zaiss D, El Morr Y, Bugaut H, Legoux F, Perrin L, Aractingi S, Golub R, Lantz O, Salou M. du Halgouet A, et al. Among authors: aractingi s. Immunity. 2023 Jan 10;56(1):78-92.e6. doi: 10.1016/j.immuni.2022.12.004. Immunity. 2023. PMID: 36630919 Free PMC article.
Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors.
Parlati L, Sakka M, Retbi A, Bouam S, Hassani L, Meritet JF, Rufat P, Bonnefont-Rousselot D, Batista R, Terris B, Bellanger A, Thabut D, Vozy A, Spano JP, Coriat R, Goldwasser F, Aractingi S, Sogni P, Pol S, Mallet V; CERTIM Research Group; DEMOSTHENES Research Group. Parlati L, et al. Among authors: aractingi s. JHEP Rep. 2023 Aug 12;5(12):100880. doi: 10.1016/j.jhepr.2023.100880. eCollection 2023 Dec. JHEP Rep. 2023. PMID: 38074948 Free PMC article.
Chemical characterization of inks in skin reactions to tattoo.
Colboc H, Bazin D, Reguer S, Lucas IT, Moguelet P, Amode R, Jouanneau C, Soria A, Chasset F, Amsler E, Pecquet C, Aractingi S, Bellot-Gurlet L, Deschamps L, Descamps V, Kluger N. Colboc H, et al. Among authors: aractingi s. J Synchrotron Radiat. 2022 Nov 1;29(Pt 6):1436-1445. doi: 10.1107/S1600577522008165. Epub 2022 Oct 4. J Synchrotron Radiat. 2022. PMID: 36345752 Free PMC article.
Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
Cohen E, Lheure C, Ingen-Housz-Oro S, Hotz C, Bettuzzi T, Chasset F, Descamps V, Deschamps L, Mahevas M, Terrier B, Sohier P, Guegan S, Kramkimel N, Darbord D, Chanal J, Oulès B, Aractingi S, Seta V, Dupin N. Cohen E, et al. Among authors: aractingi s. Eur J Dermatol. 2023 Dec 1;33(6):680-685. doi: 10.1684/ejd.2023.4584. Eur J Dermatol. 2023. PMID: 38465550
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
Lorenzon R, Ribet C, Pitoiset F, Aractingi S, Banneville B, Beaugerie L, Berenbaum F, Cacoub P, Champey J, Chazouilleres O, Corpechot C, Fautrel B, Mekinian A, Regnier E, Saadoun D, Salem JE, Sellam J, Seksik P, Vicaut E, Rosenzwajg M, Klatzmann D. Lorenzon R, et al. Among authors: aractingi s. J Autoimmun. 2024 Apr;144:103172. doi: 10.1016/j.jaut.2024.103172. Epub 2024 Feb 7. J Autoimmun. 2024. PMID: 38330545
344 results